• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	90,390	24.06.24 15:33:58	+3,000	+3,43%	90,280	90,330	87,820	87,390
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	984,600	24.06.24 08:12:32	-3,000	-0,30%	978,800	988,200	984,600	987,600